Extensive Left Ventricular Thrombosis after Recovery from COVID-19: A Case Report

Navid Shafigh1, Fatemeh Roodneshin1, Morteza Hasheminik2

  • 1Department of Anesthesiology and Critical Care Medicine, Shahid Beheshti University of Medical Science, Tehran, Iran.

Tanaffos
|December 20, 2024
PubMed

Insights

COVID-19 commonly causes coagulation disorders, leading to thrombotic complications. This case highlights an unusual extensive left ventricular thrombosis after recovery, even with anticoagulant prophylaxis.

Area of Science:

  • Cardiology
  • Hematology
  • Infectious Diseases

Background:

  • Coagulation disorders are frequent in COVID-19 patients, especially severe cases.
  • Thrombotic complications like pulmonary embolism, deep vein thrombosis (DVT), and stroke are prevalent.
  • COVID-19 coagulopathy may involve disseminated intravascular coagulation (DIC) and pulmonary thrombotic microangiopathy, impacting organ function.

Observation:

  • This case report details an unusual instance of extensive left ventricular thrombosis.
  • The thrombosis occurred in a patient who had recently recovered from COVID-19.
  • The patient was receiving anticoagulant prophylaxis at the time of the event.

Findings:

  • Left ventricular thrombosis is a rare but serious complication post-COVID-19 recovery.
  • The occurrence despite anticoagulant prophylaxis suggests complex thrombotic mechanisms.
  • This highlights the potential for significant cardiovascular complications following SARS-CoV-2 infection.

Implications:

  • Further research is needed to understand the mechanisms of post-COVID-19 thrombosis.
  • Clinical vigilance for cardiac complications in recovered COVID-19 patients is crucial.
  • Anticoagulant strategies may require re-evaluation for specific patient profiles.